Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks\u2014and life sciences companies are betting their commercial strategies on it.<\/p>\n
According to a recent report\u00a0cited\u00a0by Capgemini Invent, AI agents could generate up to US$450 billion in economic value through revenue uplift and cost savings globally by 2028, with 69% of executives planning to deploy agents in marketing processes by year\u2019s end.<\/p>\n
The stakes are particularly high in pharmaceutical marketing, where sales representatives have increasingly limited face time with healthcare professionals (HCPs)\u2014a trend accelerated by Covid-19. The challenge isn\u2019t just access; it\u2019s making those rare interactions count with intelligence that\u2019s currently trapped in data silos.<\/p>\n
The fragmented intelligence problem<\/p>\n
Briggs Davidson, Senior Director of Digital, Data & Marketing Strategy for Life Sciences at Capgemini Invent,\u00a0outlines\u00a0a scenario that will sound familiar to anyone in pharma marketing: An HCP attends a conference where a competitor showcases promising drug results, publishes research, and shifts their prescriptions to a rival product\u2014all within a single quarter.<\/p>\n
\u201cIn most companies, legacy IT infrastructure and data silos keep this information in disparate systems across CRM, events databases and claims data,\u201d Davidson writes. \u201cChances are, none of that information was accessible to sales reps before they met with the HCP.\u201d<\/p>\n
The solution, according to Davidson, isn\u2019t just connecting these systems\u2014it\u2019s deploying agentic AI in healthcare marketing to autonomously query, synthesise, and act on that unified data. Unlike conversational AI that responds to queries, agentic systems can independently execute multi-step tasks.\u00a0<\/p>\n
Instead of a data engineer building a new pipeline, an AI agent could autonomously query the CRM and claims database to answer business questions like: \u201cIdentify oncologists in the Northwest who have a 20% lower prescription volume but attended our last medical congress.\u201d<\/p>\n
From orchestration to autonomous execution<\/p>\n
Davidson frames the shift as moving from an \u201comnichannel view\u201d\u2014coordinating experiences across channels\u2014to true orchestration powered by agentic AI.<\/p>\n
In practice, this means a sales representative could have an agent assist with call and visit planning by asking: \u201cWhat messages has my HCP responded to most recently?\u201d or \u201cCan you create a detailed intelligence brief on my HCP?\u201d<\/p>\n
The agentic system would compile:<\/p>\n
Their most recent conversation with the HCP<\/p>\n
The HCP\u2019s prescribing behaviour<\/p>\n
Thought leaders the HCP follows<\/p>\n
Relevant content to share<\/p>\n
The HCP\u2019s preferred outreach channels (in-person visits, emails, webinars)<\/p>\n
More significantly, the AI agent would then create a custom call plan for each HCP based on their unified profile and recommend follow-up steps based on engagement outcomes.<\/p>\n
\u201cAgentic AI systems are about driving action, graduating from \u2018answer my prompt,\u2019 to \u2018autonomously execute my task,’\u201d Davidson explains.<\/p>\n
\u201cThat means evolving the sales representative mindset from asking questions to coordinating small teams of specialised agents that work together: one plans, another retrieves and checks content, a third schedules and measures, and a fourth enforces compliance guardrails\u2014all under human oversight.\u201d<\/p>\n
The AI-ready data prerequisite<\/p>\n
The operational promise hinges on what Davidson calls \u201cAI-ready data\u201d\u2014standardised, accessible, complete, and trustworthy information that enables three capabilities:<\/p>\n
Faster decision making:\u00a0Predictive analytics that provide near real-time alerts on what\u2019s about to happen, enabling sales representatives to act proactively.<\/p>\n
Personalisation at scale:\u00a0Delivering customised experiences to thousands of HCPs simultaneously with small human teams enabled by specialised agent networks.<\/p>\n
True marketing ROI:\u00a0Moving beyond monthly historical reports to understanding which marketing activities are actively driving prescriptions.<\/p>\n
Davidson emphasises that successful deployment starts with marketing and IT alignment on initial use cases, with stakeholders identifying KPIs that demonstrate tangible outcomes\u2014such as specific percentage increases in HCP engagement or sales representative productivity.<\/p>\n
Critical implementation questions<\/p>\n
The article notably frames agentic AI in healthcare as \u201cnot simply another technology-led capability; it\u2019s a new operating layer for commercial teams.\u201d But it acknowledges that \u201cagentic AI\u2019s full value only materialises with AI-ready data, trustworthy deployment and workflow redesign.\u201d<\/p>\n
What remains unaddressed: the regulatory and compliance complexity of autonomous systems querying claims databases containing prescriber behaviour, particularly under HIPAA\u2019s minimum necessary standard. The piece also doesn\u2019t detail actual client implementations or metrics beyond the aspirational US$450B economic value projection.<\/p>\n
For global organisations, Davidson notes that use cases \u201ccan and should be tailored to fit each market\u2019s maturity for maximum ROI,\u201d suggesting that deployment will vary significantly across regulatory environments.<\/p>\n
The fundamental value proposition, according to Davidson, centres on bidirectional benefit: \u201cThe HCP receives directly relevant content, and the marketing teams can drive increased HCP engagement and conversion.\u201d<\/p>\n
Whether that vision of autonomous marketing agents coordinating across CRM, events, and claims systems becomes standard practice by 2028\u2014or remains constrained by data governance realities\u2014will likely determine if life sciences achieves anything close to that US$450 billion opportunity.<\/p>\n
See also: China\u2019s hyperscalers bet billions on agentic AI as commerce becomes the new battleground<\/p>\n
Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx and is co-located with other leading technology events including the Cyber Security & Cloud Expo. Click here for more information.<\/p>\n
AI News is powered by TechForge Media. Explore other upcoming enterprise technology events and webinars here.
\nThe post Agentic AI in healthcare: How Life Sciences marketing could achieve US$450bn in value by 2028 appeared first on AI News.<\/p>\n","protected":false},"excerpt":{"rendered":"
Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks\u2014and life sciences companies are betting their commercial strategies on it. According to a recent report\u00a0cited\u00a0by Capgemini Invent, AI agents could generate up to US$450 billion in economic value through revenue uplift and cost savings globally by 2028, with 69% of [\u2026]<\/p>\n
The post Agentic AI in healthcare: How Life Sciences marketing could achieve US$450bn in value by 2028<\/a> appeared first on AI News<\/a>.<\/p>\n<\/div>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-container-style":"default","site-container-layout":"default","site-sidebar-layout":"default","disable-article-header":"default","disable-site-header":"default","disable-site-footer":"default","disable-content-area-spacing":"default","footnotes":""},"categories":[4,1,67,21,69,401],"tags":[3],"class_list":["post-1185","post","type-post","status-publish","format-standard","hentry","category-ai","category-ai-and-ml","category-ai-in-action","category-artificial-intelligence","category-features","category-healthcare-wellness-ai","tag-ai"],"yoast_head":"\n